Viking Therapeutics, Inc. (VKTX) forecast

Viking Therapeutics, Inc. (VKTX) forecast: price $25.89, trailing P/E n/a, forward P/E n/a. How to read the street's path.

$25.89Price

$3.29BMarket cap

n/aP/E ?

n/aForward P/E ?

n/aDividend yield ?

The live VKTX price is $25.89. Trailing P/E is n/a and forward P/E is n/a. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the VKTX forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full VKTX quote · Dividends · Price prediction · Academy

Questions

What is VKTX's forward P/E?

The latest forward P/E on Stocklytics is n/a, against a trailing P/E of n/a and a price of $25.89.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.